Annual Working Capital
$219.19 M
+$9.25 M+4.41%
December 31, 2023
Summary
- As of February 12, 2025, TARS annual working capital is $219.19 million, with the most recent change of +$9.25 million (+4.41%) on December 31, 2023.
- During the last 3 years, TARS annual working capital has risen by +$53.93 million (+32.63%).
- TARS annual working capital is now at all-time high.
Performance
TARS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$291.25 M
-$19.77 M-6.36%
September 30, 2024
Summary
- As of February 12, 2025, TARS quarterly working capital is $291.25 million, with the most recent change of -$19.77 million (-6.36%) on September 30, 2024.
- Over the past year, TARS quarterly working capital has increased by +$72.05 million (+32.87%).
- TARS quarterly working capital is now -6.36% below its all-time high of $311.02 million, reached on June 30, 2024.
Performance
TARS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TARS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.4% | +32.9% |
| 3 y3 years | +32.6% | +32.9% |
| 5 y5 years | +9845.3% | +32.9% |
TARS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +33.3% | -6.4% | +77.1% |
| 5 y | 5-year | at high | +283.1% | -6.4% | +464.1% |
| alltime | all time | at high | +9845.3% | -6.4% | +464.1% |
Tarsus Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $291.25 M(-6.4%) |
| Jun 2024 | - | $311.02 M(+4.3%) |
| Mar 2024 | - | $298.20 M(+36.0%) |
| Dec 2023 | $219.19 M(+4.4%) | $219.19 M(-7.1%) |
| Sep 2023 | - | $236.03 M(+39.9%) |
| Jun 2023 | - | $168.71 M(-13.7%) |
| Mar 2023 | - | $195.39 M(-6.9%) |
| Dec 2022 | $209.95 M | $209.95 M(-4.5%) |
| Sep 2022 | - | $219.81 M(-7.9%) |
| Jun 2022 | - | $238.56 M(+43.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $166.15 M(+1.0%) |
| Dec 2021 | $164.47 M(-0.5%) | $164.47 M(-6.9%) |
| Sep 2021 | - | $176.72 M(-7.2%) |
| Jun 2021 | - | $190.45 M(+5.0%) |
| Mar 2021 | - | $181.33 M(+9.7%) |
| Dec 2020 | $165.27 M(+188.9%) | $165.27 M(+99.3%) |
| Sep 2020 | - | $82.93 M(+60.6%) |
| Jun 2020 | - | $51.63 M(-9.8%) |
| Dec 2019 | $57.21 M(+2495.8%) | $57.21 M |
| Dec 2018 | $2.20 M | - |
FAQ
- What is Tarsus Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual working capital year-on-year change?
- What is Tarsus Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly working capital year-on-year change?
What is Tarsus Pharmaceuticals annual working capital?
The current annual working capital of TARS is $219.19 M
What is the all time high annual working capital for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual working capital is $219.19 M
What is Tarsus Pharmaceuticals annual working capital year-on-year change?
Over the past year, TARS annual working capital has changed by +$9.25 M (+4.41%)
What is Tarsus Pharmaceuticals quarterly working capital?
The current quarterly working capital of TARS is $291.25 M
What is the all time high quarterly working capital for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly working capital is $311.02 M
What is Tarsus Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, TARS quarterly working capital has changed by +$72.05 M (+32.87%)